Molecular characterisation of plasma membrane-derived vesicles

Journal of Biomedical Science

Samuel S. Antwi-Baffour¹ 

[1]Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Korle-Bu, Accra, Ghana

关键词: Microparticles;    Membrane;    Proteins;    Characterisation;    Flow-cytometry;    PMVs;   

Others  :  1225524
DOI  :  10.1186/s12929-015-0174-7

 received in 2015-03-09, accepted in 2015-07-31,  发布年份 2015

【 摘 要 】

Plasma membrane-derived vesicles (PMVs) are released into circulation in response to normal and stress/pathogenic conditions. They are of tremendous significance for the prediction, diagnosis, and observation of the therapeutic success of many diseases. Knowledge of their molecular characteristics and therefore functional properties would contribute to a better understanding of the pathological mechanisms leading to various diseases in which their levels are raised. The review aims at outlining and discussing the molecular characteristics of PMVs in order to bring to the fore some aspects/characteristics of PMVs that will assist the scientific community to properly understand the role of PMVs in various physiological and pathological processes. The review covers PMVs characterisation and discusses how distinct they are from exosomes and endosomes. Also, methods of PMVs analysis, importance of proper PMV level estimation/characterisation, PMVs and their constituents as well as their therapeutic significance are discussed. The review concludes by drawing attention to the importance of further study into the functions of the characteristics discussed which will lead to understanding the general role of PMVs both in health and in disease states.

【 授权许可】

   
2015 Antwi-Baffour.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol. 2006; 26(12):2594-604.
• [2]Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem. 1982; 122(2):429-36.
• [3]Berckmans RJ, Nieuwland R, Böing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low-grade thrombin generation. J Thromb Haemost. 2001; 85(4):639-46.
• [4]Baj-Krzyworzeka M, Majka M, Pratico D, Ratajczak J, Vilaire G, Kijowski J. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol. 2002; 30(5):450-9.
• [5]Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A et al.. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation. 2001; 104(22):2649-52.
• [6]Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006; 20:1487-95.
• [7]Ahn YS, Jy W, Jimenez JJ, Horstmann LL. More on: cellular microparticles: what are they bad or good for? J Thromb Hemost. 2004; 2:1215-6.
• [8]Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 2007; 21:157-71.
• [9]Nantakomol D, Chimma P, Day NP, Dondorp AM, Combes V, Krudsood S et al.. Quantitation of cell-derived microparticles in plasma using flow rate based calibration. Southeast Asian J Trop Med Public Health. 2008; 39(1):146-53.
• [10]Jy W, Horstmann LL, Jimenez JJ, Ahn YS. Measuring circulating cell-derived microparticles. J Thromb Haemost. 2004; 2:1842-3.
• [11]Antwi-Baffour S, Wiredu AN, Kyeremeh R, Mahmood SA. Plasma membrane-derived vesicles in sickle cell disease: a possible indicator of the continuous endothelial stimulation and/or injury to blood cells. Am J Biomed Life Sci. 2013; 1(4):99-102.
• [12]Allan D, Thomas P, Limbrick R. The isolation and characterization of 60 nm vesicles (‘nanovesicles’) produced during ionophore A23187-induced budding of human erythrocytes. Biochem J. 1980; 188:881-7.
• [13]Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci. 2000; 113:3365-74.
• [14]Hess C, Sadallah S, Hefti A, Landmann R, Schifferli JA. Ectosomes released by human neutrophils are specialized functional units. J Immunol. 1999; 163(8):4564-73.
• [15]Abid Hussein MN, Meesters EW, Osmanovic N, Romijn FP, Nieuwland R, Sturk A. Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J Thromb Haemost. 2003; 1(11):2434-43.
• [16]Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2:569-79.
• [17]Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G et al.. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009; 19:1875-85.
• [18]Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M et al.. MIFlowCyt: the minimum information about a flow cytometry experiment. Cytometry A. 2008; 73:926-30.
• [19]Pattanapanyasat K, Noulsri E, Fucharoen S, Lerdwana S, Lamchiagdhase P, Siritanaratkul N et al.. Flow cytometric quantitation of red blood cell vesicles in thalassemia. Cytometry B Clinical Cytom. 2004; 57:23-31.
• [20]Horstman LL, Jy W, Jimenez JJ, Bidot C, Ahn YS. New horizons in the analysis of circulating cell-derived microparticles. Keio J Med. 2004; 53:210-30.
• [21]Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension. 2006; 48:180-6.
• [22]Dignat-George F, Freyssinet JM, Key NS. Centrifugation is a crucial step impacting microparticle measurement. Platelets. 2009; 20:225-6.
• [23]Reich CF, Pisetsky DS. The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis. Exp Cell Res. 2009; 315:760-8.
• [24]Hind E, Heugh S, Ansa-Addo EA, Antwi-Baffour S, Lange S, Inal J. Red-cell derived plasma membrane-derived vesicles: result variability and standardization. Biochem Biophys Res Commun. 2010; 280:818-23.
• [25]Beyer C, Pisetsky DS. The role of micoparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol. 2010; 6:21-9.
• [26]Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocytederived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998; 41:1241-50.
• [27]Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2010; 15:43-51.
• [28]Loyer X, Vion AC, Tedgui A, Boulanger CM. Microvesicles as cell–cell messengers in cardiovascular diseases. Circ Res. 2014; 114:345-353.
• [29]Mathivanan S. Exosomes and shedding microvesicles are mediators of intercellular communication: how do they communicate with the target cells? J Biotechnol Biomater. 2012; 2:6.
• [30]Antwi-Baffour S, Boafo AO, Kyeremeh R, Mahmood SA. Plasma Membrane-derived Vesicles (PMVs) in G6PD deficient patients. SOJ Imunol. 2013; 1(1):4.
• [31]van Beers EJ, Schaap MC, Berckmans RJ, Nieuwland R, Sturk A, van Doormaal FF et al.. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica. 2009; 94:1513-9.
• [32]Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N et al.. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood. 2003; 102:2678-83.
• [33]MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A. Rapid secretion of interleukin-1β by microvesicle shedding. Immunity. 2001; 8:825-835.41.
• [34]Nickel W. Non-conventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic. 2005; 6:607-14.
• [35]Cestari I, Ansa-Addo E, Deolindo P, Inal JM, Ramirez MI. Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles. J Immunol. 2012; 188:1942-52.
• [36]Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and thrombosis. Scand J Immunol. 2007; 66:159-65.
• [37]Friend C, Marovitz W, Henie G, Henie W, Tsuei D, Hirschhorn K et al.. Observations on cell lines derived from a patient with Hodgkin’s disease. Cancer Res. 1978; 38:2581-91.
• [38]Ginestra A, La Placa MD, Saladino F, Cassara D, Nagase H, Vittorelli ML. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res. 1998; 18:3433-7.
• [39]Ginestra A, Miceli D, Dolo V, Romano FM, Vittorelli ML. Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res. 1999; 19:3439-45.
• [40]Szczepanski MJ, Szajnik M, Welsh A, Whiteside TL, Boyiadzis M. Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-β1. Haemotologica. 2011; 96(9):1302-9.
• [41]Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G et al.. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol. 2008; 173:1210-9.
• [42]Mostefai HA, Meziani F, Mastronardi ML, Agouni A, Heymes C, Sargentini C et al.. Circulating microparticles from septic shock patients exert protective role in vascular function. Am J Respir Crit Care Med. 2008; 178:1148-55.
• [43]Kanazawa S, Nomura S, Kuwana M, Muramatsu M, Yamaguchi K, Fukuhara S. Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer. 2003; 39:145-9.
• [44]Soleti R, Benameur T, Porro C, Panaro MA, Andriantsitohaina R, Martínez MC. Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors. Carcinogenesis. 2009; 30:580-8.
• [45]Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B et al.. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009; 2:ra81.
• [46]Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995; 1:27-31.
• [47]Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003; 3:401-10.
• [48]Gutiérrez‐Vázquez C, Villarroya‐Beltri C, Mittelbrunn M, Sánchez‐Madrid F. Transfer of extracellular vesicles during immune cell‐cell interactions. Immunol Rev. 2013; 251(1):125-42.
• [49]Van Doormaal F, Kleinjan A, Di Nisio M, Büller H, Nieuwland R. Cell-derived microvesicles and cancer. Neth J Med. 2009; 67(7):266-73.
• [50]Abid Hussein MN, Boing AN, Sturk A, Hau CM, Nieuwland R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost. 2007; 98(5):1096-107.
• [51]Inal JM, Ansa-Addo EA, Stratton D, Kholia S, Antwi-Baffour SS, Jorfi S, et al. Microvesicles in health and disease. Archivum immunologiae et therapiae experimentalis. 2012;60(2):107-21.
• [52]Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res. 2004; 64(19):7045-9.
• [53]Jaiswal R, Luk F, Dalla PV, Grau GER, Bebawy M. Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells. PLoS One. 2013; 8(4):e61515.
• [54]Bebawy M, Combes V, Lee E, Jaiswal R, Gong J, Bonhoure A et al.. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia. 2009; 23(9):1643-9.
• [55]Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 2003; 63:4331-4337.